眼肌型重症肌无力的中西医治疗进展
Progress in the Treatment of Ocular Myasthenia Gravis with Traditional Chinese and Western Medicine
DOI: 10.12677/ACM.2023.13112456, PDF,   
作者: 杨 薇：黑龙江中医药大学第一临床学院，黑龙江 哈尔滨；姚 靖*：黑龙江中医药大学附属第一医院眼科，黑龙江 哈尔滨
关键词: 眼肌型重症肌无力；胆碱酯酶抑制剂；中医治疗；Ocular Myasthenia Gravis； Cholinesterase Inhibitors； Traditional Chinese Medicine Therapy
摘要: 眼肌型重症肌无力是指肌无力症状仅累及眼外肌，其发病机制复杂，尚无根治方法，西医治疗多以胆碱酯酶抑制剂、免疫抑制剂、胸腺切除术等为主，中医在辩证使用中药，脏腑论治及针灸等中医特色治疗取得了满意的疗效。中医和西医治疗皆有其优势与不足，为弥补单纯中医或西医治疗存在的缺陷，以获得更好的临床效果，可采用中西医结合的治疗方式以有效缩短病程、降低复发率、提高疾病的预后。
Abstract: Ocular myasthenia gravis refers to myasthenia symptoms that only involve the extraocular muscle, its pathogenesis is complex, there is no cure, Western medicine treatment mainly cholinesterase inhibitors, immunosuppressants, thymectomy, etc. Chinese medicine in the dialectical use of Chi-nese medicine, zangfu treatment and acupuncture and other Chinese characteristics of treatment has achieved satisfactory results. Both traditional Chinese medicine and Western medicine have their advantages and disadvantages. In order to make up for the shortcomings of simple Chinese medicine or Western medicine treatment and obtain better clinical results, the combination of Chi-nese and Western medicine can be used to effectively shorten the course of disease, reduce the re-currence rate and improve the prognosis of the disease.
文章引用：杨薇, 姚靖. 眼肌型重症肌无力的中西医治疗进展[J]. 临床医学进展, 2023, 13(11): 15731-17535. https://doi.org/10.12677/ACM.2023.13112456

参考文献

[1] 徐鹏, 吕志国, 王健, 等. 重症肌无力中医循证性临床诊疗指南修订实践研究[J]. 中华中医药杂志, 2018, 33(5): 1979-1983.
[2] 常婷. 中国重症肌无力诊断和治疗指南(2020版) [J]. 中国神经免疫学和神经病学杂志, 2021, 28(1): 1-12.
[3] 张慜, 李柱一. 眼肌型和全身型重症肌无力的差异[J]. 中国神经免疫学和神经病学杂志, 2012, 19(6): 413-416.
[4] 沈洁, 陈园园, 董云, 等. 基于数据挖掘探讨中医药治疗眼肌型重症肌无力的用药规律[J]. 中国中医药科技, 2023, 30(5): 1034-1037.
[5] Kerty, E., Elsais, A., Argov, Z., Evoli, A. and Gilhus, N.E. (2014) EFNS/ENS Guidelines for the Treatment of Ocular Myasthenia. European Journal of Neurology, 21, 687-693. [Google Scholar] [CrossRef] [PubMed]
[6] Europa, T.A., Nel, M. and Heckmann, J.M. (2018) Myasthenic Ophthal-moparesis: Time To Resolution after Initiating Immune Therapies. Muscle & Nerve, 58, 542-549. [Google Scholar] [CrossRef] [PubMed]
[7] O’Hare, M. and Doughty, C. (2019) Update on Ocular Myasthenia Gravis. Seminars in Neurology, 39, 749-760. [Google Scholar] [CrossRef] [PubMed]
[8] Monsul, N.T., Patwa, H.S., Knorr, A.M., Lesser, R.L. and Goldstein, J.M. (2004) The Effect of Prednisone on the Progression from Ocular to Generalized Myasthenia Gravis. Journal of the Neurological Sciences, 217, 131-133. [Google Scholar] [CrossRef] [PubMed]
[9] Sommer, N., Sigg, B., Melms, A., Weller, M., Schepelmann, K., Herzau, V. and Dichgans, J. (1997) Ocular Myasthenia Gravis: Response to Long-Term Immunosuppressive Treatment. Journal of Neurology, Neurosurgery & Psychiatry, 62, 156-162. [Google Scholar] [CrossRef] [PubMed]
[10] 赵卫浩, 崔新征, 马文强, 等. 胸腺切除术对眼肌型重症肌无力的疗效[J]. 郑州大学学报(医学版), 2021, 56(6): 754-757.
[11] Hamedani, A.G., Pistilli, M., Singhal, S., et al. (2020) Outcomes after Transcervical Thymectomy for Oc-ular Myasthenia Gravis: A Retrospective Cohort Study with Inverse Probability Weighting. Journal of Neu-ro-Ophthalmology, 40, 8-14. [Google Scholar] [CrossRef] 
[12] 黄剑浩, 谢宇锋, 冯军, 等. 冯军运用颅项针“通调肝气”治疗眼肌型重症肌无力经验[J]. 中医药导报, 2020, 26(9): 190-192.
[13] 李琛妮, 付于. 皮部浅刺法治疗眼肌型重症肌无力[J]. 河南中医, 2018, 38(3): 458-460.
[14] 张明, 杨涛, 李贺, 等. 韩碧英治疗眼肌型重症肌无力经验[J]. 北京中医药, 2022, 41(8): 865-866.
[15] 黄泰琼, 何世莲. 眼针结合补中益气汤治疗眼肌型重症肌无力脾虚型临床观察[J]. 实用中医药杂志, 2022, 38(5): 723-725.
[16] 胡文静, 杜旭, 李銛鋆, 等. 电针结合补中益气汤治疗眼肌型重症肌无力的临床观察[J]. 中国中医眼科杂志, 2021, 31(8): 561-565.
[17] 阳艳, 俞晓艺, 关国华, 等. 关国华教授针药结合治疗眼肌型重症肌无力经验[J]. 中国中医药现代远程教育, 2020, 18(12): 50-52.
[18] 邹月兰, 朱梦钧, 丁琦, 等. 八珍汤加减治疗气血两虚证眼肌型重症肌无力疗效观察[J]. 中医临床研究, 2021, 13(27): 131-133.
[19] 王利军, 姚威, 宋晓杰, 等. 复肌宁汤联合免疫抑制剂治疗眼肌型重症肌无力疗效观察及对免疫学指标的影响[J]. 新中医, 2020, 52(11): 54-56.
[20] 徐先鹏, 江沿兵, 管丽华, 等. 针药结合治疗眼肌型重症肌无力: 随机对照试验[J]. 中国针灸, 2022, 42(7): 755-759.

为你推荐